{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:54:43Z","timestamp":1782604483318,"version":"3.54.5"},"reference-count":46,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The clinical management of pediatric liver tumors involves stratification into risk groups. One previously defined, high-risk group of hepatoblastomas is the small cell undifferentiated variant. In light of molecular studies showing SMARCB1 deletion in these tumors, it is now recognized that most small cell, undifferentiated liver tumors represent an aggressive unrelated tumor\u2014the malignant rhabdoid tumor (MRT). SMARCB1 is a member of the chromatin remodeling SWI\/SNF complex and encodes the INI1 protein. The histologic diagnosis of MRT is currently based on INI1 negative immunoreactivity and the presence of rhabdoid morphology. INI1-negative small cell liver tumors lacking classic rhabdoid morphology are often misclassified as small cell undifferentiated hepatoblastomas (SCUD-HB), according to the current classification. Pediatric liver tumors diagnosed between 2003\u20132017 as SCUD-HB (four cases) or MRT (two cases) were identified from the Columbia University Pathology Department Archives. All tumors were associated with normal or low serum alpha fetoprotein levels, and showed an absence of immunohistochemical staining of hepatocellular markers (Hep-par1, Arginase) and loss of INI1 staining. Two cases were initially diagnosed as MRT, one with prominent rhabdoid morphology, the other with predominant small cell morphology. The remaining four cases with small cell morphology were classified as SCUD-HB. Ancillary molecular studies confirmed the loss of SMARCB1, supporting the diagnosis of MRT in all cases, proving morphology an unreliable criterion. It is critical to eliminate the term INI1-negative hepatoblastoma from the current classification scheme, and classify INI1-negative tumors as MRT, particularly since high-risk HB-chemotherapy regimens are not effective for treating MRT.<\/jats:p>","DOI":"10.3390\/cancers11121992","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:20:16Z","timestamp":1576120816000},"page":"1992","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma"],"prefix":"10.3390","volume":"11","author":[{"given":"Ladan","family":"Fazlollahi","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Kochhar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Columbia University Irving Medical Center; New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh M.","family":"Mansukhani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell J.","family":"Yamashiro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA"},{"name":"Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Columbia University Irving Medical Center; New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Remotti","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0046-8177(87)80161-2","article-title":"Malignant rhabdoid tumor of the central nervous system","volume":"18","author":"Biggs","year":"1987","journal-title":"Hum. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01052653","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood","volume":"24","author":"Rorke","year":"1995","journal-title":"J. Neurooncol."},{"key":"ref_3","first-page":"107","article-title":"2000 World Health Organization classification of tumors of the nervous system","volume":"51","author":"Biernat","year":"2000","journal-title":"Pol. J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U","article-title":"Histopathology and prognosis of Wilms tumors: Results from the First National Wilms\u2019 Tumor Study","volume":"41","author":"Beckwith","year":"1978","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/1097-0142(19841115)54:10<2137::AID-CNCR2820541014>3.0.CO;2-D","article-title":"The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases","volume":"54","author":"Bonnin","year":"1984","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(19820601)49:11<2365::AID-CNCR2820491125>3.0.CO;2-I","article-title":"Infantile sarcoma with intracytoplasmic filamentous inclusions: Distinctive tumor of possible histiocytic origin","volume":"49","author":"Goldschmidt","year":"1982","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pbc.21632","article-title":"Extra-renal non-cerebral rhabdoid tumours","volume":"51","author":"Bourdeaut","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1097-0142(19930415)71:8<2653::AID-CNCR2820710834>3.0.CO;2-#","article-title":"Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide","volume":"71","author":"Gururangan","year":"1993","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/pbc.22857","article-title":"Rhabdoid tumors of the liver: Rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy","volume":"57","author":"Finegold","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/MPH.0b013e3181b79613","article-title":"INI1 (BAF 47) immunohistochemistry is an essential diagnostic tool for children with hepatic tumors and low alpha fetoprotein","volume":"32","author":"Sughayer","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2015013566","article-title":"Biology and Treatment of Rhabdoid Tumor","volume":"20","author":"Geller","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"ref_12","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y","article-title":"Narrowing the critical region for a rhabdoid tumor locus in 22q11","volume":"16","author":"Biegel","year":"1996","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/gcc.2870050203","article-title":"Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor","volume":"5","author":"Biegel","year":"1992","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/cbt.8.5.8019","article-title":"The role of SMARCB1\/INI1 in development of rhabdoid tumor","volume":"8","author":"Roberts","year":"2009","journal-title":"Cancer Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2350\/14-07-1531-MISC.1","article-title":"Rhabdoid tumor predisposition syndrome","volume":"18","author":"Sredni","year":"2015","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1073\/pnas.91.8.2905","article-title":"Five SWI\/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement","volume":"91","author":"Peterson","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/pbc.21893","article-title":"SMARCB1\/INI1 alterations and hepatoblastoma: Another extrarenal rhabdoid tumor revealed?","volume":"52","author":"Russo","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/01.pas.0000141390.14548.34","article-title":"Immunohistochemical analysis of hSNF5\/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors","volume":"28","author":"Hoot","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2350\/06-08-0155.1","article-title":"Malignant rhabdoid tumor mimicking hepatoblastoma: A case report and literature review","volume":"10","author":"Wagner","year":"2007","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Alaggio","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_25","unstructured":"Rudzinski, E., Ranganathan, S., Hicks, J., Kim, G., and College of American Pathologists (2019, August 26). Protocol for the Examination of Specimens from Pediatric Patients with Hepatoblastoma. Available online: http:\/\/www.cap.org\/ShowProperty?nodePath=\/UCMCon\/Contribution%20Folders\/WebContent\/pdf\/cp-hepatoblast-16protocol-3202.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pbc.21834","article-title":"Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumors","volume":"52","author":"Tomlinson","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.humpath.2014.12.013","article-title":"Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable?","volume":"46","author":"Zhou","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jmoldx.2016.10.008","article-title":"Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement","volume":"19","author":"Sireci","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13073-016-0389-6","article-title":"Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations","volume":"8","author":"Oberg","year":"2016","journal-title":"Genome Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/gb-2013-14-10-r120","article-title":"EXCAVATOR:detecting copy number variants from whole-exome sequencing data","volume":"14","author":"Magi","year":"2013","journal-title":"Genome Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ehpc.2018.02.001","article-title":"INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor","volume":"12","author":"Fazlollahi","year":"2018","journal-title":"Hum. Pathol. Case Rep."},{"key":"ref_32","first-page":"323","article-title":"The role of INI1 and the SWI\/SNF complex in the development of rhabdoid tumors: Meeting summary from the workshop on childhood atypical teratoid\/rhabdoid tumors","volume":"62","author":"Biegel","year":"2002","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","article-title":"No small surprise\u2014Small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour","volume":"233","author":"Foulkes","year":"2014","journal-title":"J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pbc.20526","article-title":"Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome","volume":"47","author":"Fruhwald","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajhg.2010.01.013","article-title":"Germline nonsense mutation and somatic inactivation of SMARCA4\/BRG1 in a family with rhabdoid tumor predisposition syndrome","volume":"86","author":"Schneppenheim","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.4225","article-title":"Familial rhabdoid tumour \u2018avant la lettre\u2019\u2014From pathology review to exome sequencing and back again","volume":"231","author":"Witkowski","year":"2013","journal-title":"J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00000478-199809000-00007","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study","volume":"22","author":"Burger","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/gcc.22390","article-title":"Small Cell Undifferentiated Hepatoblastomas (SCUD): All Malignant Rhabdoid Tumors?","volume":"55","author":"Vokuhl","year":"2016","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/cncr.26684","article-title":"Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: A multicenter study","volume":"118","author":"Dufour","year":"2012","journal-title":"Cancer"},{"key":"ref_40","unstructured":"Saxena, R., and Quaglia, A. (2019). WHO Classification of Tumours Editorial Board. Hepatoblastoma. Digestive System Tumours, International Agency for Research on Cancer. [5th ed.]."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jpedsurg.2017.09.005","article-title":"Rhabdoid tumor of the liver: Report of 6 pediatric cases treated at a single institute","volume":"53","author":"Cornet","year":"2018","journal-title":"J. Pediatr. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-18-2675","article-title":"A Phase 2 Study of Alisertib in Children with Recurrent\/Refractory Solid Tumors or Leukemia: Children\u2019s Oncology Group Phase 1 and Pilot Consortium ADVL0921)","volume":"25","author":"Mosse","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.02.027","article-title":"Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005","volume":"60","author":"Brennan","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/pbc.20947","article-title":"Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors","volume":"50","author":"Puri","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/pbc.24271","article-title":"A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children\u2019s Oncology Group phase I consortium study (ADVL0916)","volume":"60","author":"Muscal","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1992\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:41:29Z","timestamp":1760190089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cancers11121992"],"URL":"https:\/\/doi.org\/10.3390\/cancers11121992","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]}}}